Universal Detection Technology Completes Sale Of Two Anthrax Detection Systems To The British Government
Main Category: Bio-terrorism / TerrorismArticle Date: 26 Oct 2006 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Universal Detection Technology (OTC Bulletin Board: UDTT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, announced that it has completed the sale of two of its BSM-2000 Anthrax Detectors to the Government of the United Kingdom. Universal Detection is not disclosing the specific branch of the government that purchased the units or any other details about their location and deployment. The two units were sold pursuant to a purchase order on February of 2006 from the British Government and have been shipped and now received, and Universal Detection Technology has received payment thus completing the sale. The sale comes in the wake of the five year anniversary of the deadly Anthrax attacks in the United States.
"The sale of multiple units of our BSM-2000 to a government of such stature is a significant milestone for Universal Detection Technology. We are extremely pleased to have concluded this contract and to have delivered 2 units of our BSM-2000 to the Government of the United Kingdom," said Jacques Tizabi, CEO of Universal Detection Technology.
For more information on Universal Detection Technology, please visit our website: http://www.udetection.com.
To view a recent feature on Universal Detection Technology on KNBC TV, please visit: http://www.udetection.com/pressroom-video-NBC1006.htm.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bio-terrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA has developed a bio-terror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
Universal Detection Technology
http://www.udetection.com
Visit our bio-terrorism / terrorism section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/55105.php>
APA
http://www.medicalnewstoday.com/releases/55105.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



